SANOFI-ADR (SNY) Fundamental Analysis & Valuation

NASDAQ:SNY • US80105N1054

Current stock price

47.6 USD
-0.29 (-0.61%)
At close:
47.74 USD
+0.14 (+0.29%)
After Hours:

This SNY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. SNY Profitability Analysis

1.1 Basic Checks

  • In the past year SNY was profitable.
  • In the past year SNY had a positive cash flow from operations.
  • SNY had positive earnings in each of the past 5 years.
  • SNY had a positive operating cash flow in each of the past 5 years.
SNY Yearly Net Income VS EBIT VS OCF VS FCFSNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNY has a better Return On Assets (9.85%) than 91.15% of its industry peers.
  • SNY has a Return On Equity of 17.49%. This is amongst the best in the industry. SNY outperforms 89.58% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.76%, SNY belongs to the top of the industry, outperforming 93.23% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SNY is significantly below the industry average of 13.06%.
  • The 3 year average ROIC (7.41%) for SNY is below the current ROIC(13.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROIC 13.76%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNY Yearly ROA, ROE, ROICSNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 17.71%, SNY belongs to the best of the industry, outperforming 91.15% of the companies in the same industry.
  • SNY's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 23.28%, SNY belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SNY has grown nicely.
  • With a decent Gross Margin value of 72.55%, SNY is doing good in the industry, outperforming 79.17% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SNY has remained more or less at the same level.
Industry RankSector Rank
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNY Yearly Profit, Operating, Gross MarginsSNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SNY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNY is creating value.
  • The number of shares outstanding for SNY has been reduced compared to 1 year ago.
  • SNY has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SNY is higher compared to a year ago.
SNY Yearly Shares OutstandingSNY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SNY Yearly Total Debt VS Total AssetsSNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • The Debt to FCF ratio of SNY is 1.86, which is an excellent value as it means it would take SNY, only 1.86 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SNY (1.86) is better than 94.27% of its industry peers.
  • A Debt/Equity ratio of 0.22 indicates that SNY is not too dependend on debt financing.
  • The Debt to Equity ratio of SNY (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Altman-Z N/A
ROIC/WACC1.84
WACC7.46%
SNY Yearly LT Debt VS Equity VS FCFSNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that SNY should not have too much problems paying its short term obligations.
  • SNY's Current ratio of 1.09 is on the low side compared to the rest of the industry. SNY is outperformed by 82.29% of its industry peers.
  • SNY has a Quick Ratio of 1.09. This is a normal value and indicates that SNY is financially healthy and should not expect problems in meeting its short term obligations.
  • SNY's Quick ratio of 1.09 is on the low side compared to the rest of the industry. SNY is outperformed by 76.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SNY Yearly Current Assets VS Current LiabilitesSNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SNY Growth Analysis

3.1 Past

  • SNY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.82%.
  • SNY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.58% yearly.
  • Looking at the last year, SNY shows a small growth in Revenue. The Revenue has grown by 5.29% in the last year.
  • SNY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.57% yearly.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • Based on estimates for the next years, SNY will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue Next Year7.45%
Revenue Next 2Y6.54%
Revenue Next 3Y6.06%
Revenue Next 5Y5.29%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SNY Yearly Revenue VS EstimatesSNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNY Yearly EPS VS EstimatesSNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. SNY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.46, which indicates a very decent valuation of SNY.
  • SNY's Price/Earnings ratio is rather cheap when compared to the industry. SNY is cheaper than 89.58% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.21. SNY is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 9.64, the valuation of SNY can be described as very reasonable.
  • 88.54% of the companies in the same industry are more expensive than SNY, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of SNY to the average of the S&P500 Index (23.13), we can say SNY is valued rather cheaply.
Industry RankSector Rank
PE 10.46
Fwd PE 9.64
SNY Price Earnings VS Forward Price EarningsSNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 92.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.14
EV/EBITDA N/A
SNY Per share dataSNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of SNY may justify a higher PE ratio.
PEG (NY)1.24
PEG (5Y)1.87
EPS Next 2Y6.95%
EPS Next 3Y8.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SNY Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.03%, SNY is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.64, SNY pays a better dividend. On top of this SNY pays more dividend than 96.88% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, SNY pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.03%

5.2 History

  • The dividend of SNY has a limited annual growth rate of 4.30%.
  • SNY has paid a dividend for at least 10 years, which is a reliable track record.
  • SNY has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
SNY Yearly Dividends per shareSNY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • The dividend of SNY is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y6.95%
EPS Next 3Y8.43%
SNY Yearly Income VS Free CF VS DividendSNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

SNY Fundamentals: All Metrics, Ratios and Statistics

SANOFI-ADR

NASDAQ:SNY (4/6/2026, 8:09:07 PM)

After market: 47.74 +0.14 (+0.29%)

47.6

-0.29 (-0.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.23%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap114.96B
Revenue(TTM)70.49B
Net Income(TTM)12.49B
Analysts76
Price Target57.52 (20.84%)
Short Float %0.34%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield 5.03%
Yearly Dividend2.2
Dividend Growth(5Y)4.3%
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.22%
Min EPS beat(2)4.58%
Max EPS beat(2)5.86%
EPS beat(4)3
Avg EPS beat(4)3.54%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)6
Avg EPS beat(8)4.07%
EPS beat(12)8
Avg EPS beat(12)3.12%
EPS beat(16)11
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)6
Avg Revenue beat(16)14.04%
PT rev (1m)0%
PT rev (3m)-7.61%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)4.88%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)2.63%
Revenue NQ rev (3m)0.79%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 10.46
Fwd PE 9.64
P/S 1.42
P/FCF 9.14
P/OCF 9.14
P/B 1.4
P/tB 26.15
EV/EBITDA N/A
EPS(TTM)4.55
EY9.56%
EPS(NY)4.94
Fwd EY10.37%
FCF(TTM)5.21
FCFY10.94%
OCF(TTM)5.21
OCFY10.94%
SpS33.64
BVpS34.06
TBVpS1.82
PEG (NY)1.24
PEG (5Y)1.87
Graham Number59.05
Profitability
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROCE 16.67%
ROIC 13.76%
ROICexc 14.92%
ROICexgc 58.3%
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
FCFM 15.49%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 87.43%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z N/A
F-Score5
WACC7.46%
ROIC/WACC1.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year7.45%
Revenue Next 2Y6.54%
Revenue Next 3Y6.06%
Revenue Next 5Y5.29%
EBIT growth 1Y7.73%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.69%
EBIT Next 3Y14.49%
EBIT Next 5Y9.74%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI-ADR / SNY Fundamental Analysis FAQ

What is the fundamental rating for SNY stock?

ChartMill assigns a fundamental rating of 6 / 10 to SNY.


Can you provide the valuation status for SANOFI-ADR?

ChartMill assigns a valuation rating of 7 / 10 to SANOFI-ADR (SNY). This can be considered as Undervalued.


Can you provide the profitability details for SANOFI-ADR?

SANOFI-ADR (SNY) has a profitability rating of 8 / 10.


Can you provide the financial health for SNY stock?

The financial health rating of SANOFI-ADR (SNY) is 5 / 10.